Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
SINOPEC CORP
00386
5
CNOOC
00883
| (Q1)Mar 31, 2026 | (FY)Dec 31, 2025 | (Q4)Dec 31, 2025 | (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 8.68%1.27B | 5.22%7.05B | 11.63%2.23B | 7.84%1.91B | -3.75%1.75B | 4.21%1.16B | -3.82%6.7B | -17.32%2B | 17.33%1.77B | -8.66%1.81B |
| Net income from continuing operations | -1.29%1.15B | 6.12%4.72B | 8.90%1.25B | 4.98%1.14B | 5.21%1.17B | 5.26%1.16B | -20.92%4.45B | -46.20%1.15B | -2.08%1.09B | -4.54%1.11B |
| Operating gains losses | -63.11%-168M | -33.55%-410M | -8.25%-105M | -6.32%-101M | -405.00%-101M | -8.42%-103M | 43.88%-307M | 58.37%-97M | 8.65%-95M | 80.95%-20M |
| Depreciation and amortization | -1.83%484M | 2.43%1.94B | -6.75%456M | 5.26%500M | 4.94%489M | 6.71%493M | 4.13%1.89B | 5.62%489M | 3.94%475M | 3.79%466M |
| Deferred tax | 114.29%45M | 2.77%334M | 700.00%144M | -39.47%92M | -11.49%77M | -69.12%21M | 212.85%325M | 103.05%18M | 22.58%152M | -20.18%87M |
| Other non cashItems | -74.47%12M | 21.29%302M | 97.67%170M | 143.75%78M | -89.23%7M | -28.79%47M | -39.42%249M | -58.25%86M | -47.54%32M | 58.54%65M |
| Change In working capital | 44.18%-254M | 79.35%165M | -11.05%314M | 64.00%205M | 0.00%101M | 6.57%-455M | 273.58%92M | -19.41%353M | 193.28%125M | -68.83%101M |
| -Change in receivables | -42.05%-125M | -55.12%92M | 0.00%132M | -1,560.00%-83M | 43.96%131M | -576.92%-88M | 188.73%205M | 833.33%132M | 90.91%-5M | -44.85%91M |
| -Change in inventory | -4.55%-92M | -300.00%-24M | 152.94%43M | -27.12%43M | -633.33%-22M | -11.39%-88M | 66.67%-6M | -61.36%17M | 637.50%59M | -200.00%-3M |
| -Change in payables and accrued expense | 85.40%-20M | 305.61%220M | -17.68%149M | 23,200.00%233M | -47.06%-25M | 49.63%-137M | 43.98%-107M | -47.08%181M | 101.23%1M | -116.19%-17M |
| -Change in other current assets | 88.03%-17M | ---123M | -143.48%-10M | -82.86%12M | -43.33%17M | -15.45%-142M | --0 | -67.14%23M | 1,266.67%70M | -41.18%30M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 8.68%1.27B | 5.22%7.05B | 11.63%2.23B | 7.84%1.91B | -3.75%1.75B | 4.21%1.16B | -3.82%6.7B | -17.32%2B | 17.33%1.77B | -8.66%1.81B |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 32.16%-365M | -2.94%-3.71B | -27.93%-1.23B | 5.88%-1.12B | 4.97%-823M | 8.50%-538M | -4.01%-3.61B | 19.08%-963M | -27.82%-1.19B | 2.15%-866M |
| Net PPE purchase and sale | 31.60%-355M | -3.07%-3.66B | -30.19%-1.23B | 6.04%-1.11B | 5.63%-805M | 9.90%-519M | -16.06%-3.55B | -17.27%-944M | -28.24%-1.18B | 2.51%-853M |
| Net business purchase and sale | ---- | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- |
| Net other investing changes | 47.37%-10M | 5.17%-55M | 84.21%-3M | -7.14%-15M | -38.46%-18M | -58.33%-19M | -190.00%-58M | -480.00%-19M | 0.00%-14M | -30.00%-13M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 32.16%-365M | -2.94%-3.71B | -27.93%-1.23B | 5.88%-1.12B | 4.97%-823M | 8.50%-538M | -4.01%-3.61B | 19.08%-963M | -27.82%-1.19B | 2.15%-866M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 13.41%-678M | 6.88%-3.37B | 35.71%-857M | -80.72%-1.21B | 49.07%-522M | -32.04%-783M | -6.28%-3.62B | -7.50%-1.33B | -6.02%-669M | 1.91%-1.03B |
| Net issuance payments of debt | 705.43%781M | -14.76%907M | 139.79%306M | 9.09%348M | -32.86%382M | -113.65%-129M | -66.87%1.06B | -288.48%-769M | -69.96%319M | 8.17%569M |
| Net common stock issuance | -451.23%-893M | 20.19%-2.12B | -286.71%-611M | -133.48%-1.04B | 72.28%-303M | 83.02%-162M | 42.13%-2.65B | 86.37%-158M | 62.95%-445M | -3.90%-1.09B |
| Cash dividends paid | -0.18%-558M | -3.27%-2.21B | -2.64%-545M | -3.38%-550M | -3.93%-556M | -3.15%-557M | -3.24%-2.14B | -4.32%-531M | -3.30%-532M | -2.69%-535M |
| Proceeds from stock option exercised by employees | -2.70%36M | 41.67%51M | 200.00%9M | -80.00%1M | -20.00%4M | 60.87%37M | -20.00%36M | -81.25%3M | 400.00%5M | -68.75%5M |
| Net other financing activities | -257.14%-44M | -108.82%-6M | -113.11%-16M | 293.75%31M | -268.97%-49M | 141.79%28M | 623.08%68M | 2,950.00%122M | -172.73%-16M | 307.14%29M |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 13.41%-678M | 6.88%-3.37B | 35.71%-857M | -80.72%-1.21B | 49.07%-522M | -32.04%-783M | -6.28%-3.62B | -7.50%-1.33B | -6.02%-669M | 1.91%-1.03B |
| Net cash flow | ||||||||||
| Beginning cash position | -9.48%363M | -56.60%401M | -67.62%226M | -18.37%640M | -71.66%244M | -56.60%401M | 10.79%924M | -25.90%698M | -20.81%784M | -8.11%861M |
| Current changes in cash | 241.40%222M | 93.37%-35M | 145.85%138M | -389.41%-416M | 612.82%400M | -145.31%-157M | -680.22%-528M | -1,670.59%-301M | -70.00%-85M | -241.82%-78M |
| Effect of exchange rate changes | --1M | -160.00%-3M | -125.00%-1M | 300.00%2M | -500.00%-4M | --0 | 600.00%5M | 500.00%4M | -150.00%-1M | 150.00%1M |
| Cash adjustments other than cash changes | -8.33%-13M | ---- | ---- | ---- | ---- | ---12M | ---- | ---- | ---- | ---- |
| End cash Position | 146.98%573M | -9.48%363M | -9.48%363M | -67.62%226M | -18.37%640M | -73.05%232M | -56.60%401M | -56.60%401M | -25.90%698M | -20.81%784M |
| Free cash from | 28.06%826M | 7.65%3.39B | -5.04%998M | 35.12%808M | -2.08%940M | 19.22%645M | -16.62%3.15B | -28.94%1.05B | 0.50%598M | -13.51%960M |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.